al. 1988). We aimed to use anti-BSA mAbs for multi-purposes such as the analysis and depletion of BSA from the culture medium containing fetal calf serum. To obtain a large quantity of anti-BSA mAbs which recognize distinct epitopes on BSA, we newly prepared mAbs for BSA and determined the epitopes recognized by these mAbs. In this article, we describe the immunological properties of the anti-BSA mAbs and their application to quantitative analysis of BSA and to depletion of BSA from culture medium.
MATERIALS AND METHODS

Albumin and animals
Bovine, human, rat, mouse and dog serum albumins (fraction V) and ovalbumin (grade III) were purchased from Sigma Co.(St. Louis, MO, USA). Male BALB/c mice were obtained from Japan SLC, Inc. (Hamamatsu) and used at 7 to 9 weeks of age.
Preparation of anti-BSA mAbs
For immunization, BSA was dissolved in phosphate-buffered saline (PBS), pH 7.4, and emulsified with an equal volume of incomplete Freund's adjuvant (Difco Laboratories, Detroit, MI, USA). Mice were immunized by i.p. injections of the emulsion containing 100 mg of BSA 3 times at 2-week intervals. Three days after the final booster immunization, spleen cells were obtained from the mice and an aliquot (6 x 10') of the cells were fused with P3X63Ag8.653 mouse myeloma cells (6 X 106) in the presence of 50% polyethelylene glycol 1540 (PEG1540, Wako Pure Chemical Industries, Osaka) at 37°C. Hybridomas were selected in hypoxanthine-aminopterine-thymidine (HAT) medium and then cultured in serum-free Hymedium 606 (Kojin Co., Tokyo). Twenty two hybridoma cell lines secreting anti-BSA antibodies were selected by testing the culture supernatants with enzyme-linked immunosorbent assay (ELISA). Three of them, designated as AB-3, AB-4 and AB-6, were cloned by the limiting dilution method using myeloma cells as feeder. Cloned hybridoma cells (5 x 106) were injected i.p. into mice primed with pristane (2, 6, 10, 14-tetramethylpentadecane, Wako Pure Chemical Industries) before one week. Ascites fluid was collected 7 to 12 days after injection, and centrifuged to separate cells and debris. Supernatant (cleared ascites fluid) was precipitated by 50% saturated ammonium sulfate and the resultant pellet was dissolved in PBS. The solution was dialyzed against 0.03 M phosphate buffer (pH 8.0) and further purified with a DEAE (Whatman Ltd., Maidstone, England) column.
Isotypes of three anti-BSA mAb were determined by multispot ELISA as described before (Hawkes et al. 1982 ). All three mAbs were IgGI.
Preparation of 1251-labeled mAb '25I-labeled mAb was prepared by using Iodogen method (Fraker and Speck 1978) . In brief, an aliquot (90 p l) of mAb solution (167 p g/ml) and 10 p 1 of 200 p Ci/ml Na125I (Amersham Laboratories, Buckinghamshire, England) were mixed in an Iodogen-coated glass tube. Labeled mAbs were seperated from free 125I with a Sephadex G-50 (Pharmacia LKB, Uppsala, Sweden) column.
Preparation of biotinylated mAb
After dialysis against 0.1 M NaHCO3 solution, 2 ml of AB-3 mAb solution (1 mg/ml) was treated with 100,1 of N-hydroxysuccinimidobiotin (NHS-Biotin, Pierce Chemical Co., Rockford, IL, USA) solution (1 mg/ml) in N, N-dimethylformamide for 3 hr at room temperature. Before dialysis against PBS, 100,1 of 0.5% (w/v) glycine solution was added to stop the reaction. Biotinylated AB-3 was used in sandwich ELISA at a concen- Preparation of mAb-coupled affinity gel Two ml of mAb solution (8-10 mg/ml) dialyzed against 0.05 M carbonate buffer (pH 8.5) was added to 100 mg of 2-fluoro-l-methylpyridinium toluene-4-sulfonate (FMP)-activated Cellulofine (Seikagaku Kogyo Co., Tokyo) and incubated for 18 hr at 4°C. After washing out unreacted mAb, gel was blocked with 0.01 M Tris buffer (pH 8.9) containing 0.1 M monoethanol amine for 16 hr at 4°C. After extensive washing, 50% of gel suspension in PBS was prepared for use. MAb bound to the affinity gel was quantified by the method of Lowry (Lowry et al. 1951) . As a control, we used B3 mAb (mouse IgGi) which recognized a cell proliferation-related antigen, gp125 of the rat (Hashimoto et al. 1983 ). B3-binding affinity gel was used as control.
Binding inhibition assay
Polystylene beads (6.35 nun diameter, Sumitomo Bakelite, Tokyo) were coated with 1% BSA-PBS overnight at 4°C. After washing with PBS, BSA-coated beads were treated with 0.5% gelatin-PBS overnight at 4°C and then mixed with 150,u1 of unlabeled mAb (2, 20 or 200 pg/ml in 0.05% Tween-PBS) and 150,u1 of '251-labeled mAb (3 x 105 cpm/tube). After incubation for 3 hr at 37°C, the beads were washed four times with 0.05% Tween-PBS, and radioactivities bound to BSA were measured by a y-ray scintillation counter (Aloka Co., Tokyo). The percent inhibition was calculated as follows:
Inhibition %= 1-S-A x 100 B -A Where S (sample) is cpm of a sample with an inhibitor mAb; A is cpm of a sample with 1% BSA-PBS; B is cpm of a sample with 0.5% gelatin-PBS.
Reactivity of mAb to albumins from various animals
Reactivities of anti-BSA mAb to albumins other than BSA were assessed by determining the inhibitory effect of albumin (0.2 and 2-mg/ml) on the binding of anti-BSA mAb to BSA. The inhibition percent (%) was calculated by above equation.
Sandwich ELISA BSA in test samples was analyzed by regular sandwich ELISA. Polyvinylchloride 96-well microtiter plates (type E; Sumitomo Bakelite) were coated with capture antibody, AB-6, by incubation with 50 ,ul of purified antibody (30 pg/ml) in PBS at 4°C overnight. Residual unsaturated sites on each well were blocked by treating with 0.5% (w/v) low fat dry skimmed milk (Yukijirushi Co., Tokyo) solution in PBS at 37°C for 2 hr. An aliquot (50 j l) of a test sample in 0.05% Tween-PBS was added to the wells and incubated for 1 hr at 37°C. After washing, the wells were successively treated with 50,ul of biotinylated AB-3 (10 Jug/ml), horseradish peroxidase-labeled avidin D (1 Jug/ml, Vector Lab., Burlingame, CA, USA), and 0.1 M sodium acetate-citrate buffer (pH 6.0) containing 0.03% 11202 and 3, 3', 5, 5'-tetramethyl benzidine (0.1 mg/ml). The reaction was terminated by addition of 0.5 N H2SO4 and developed color was measured at 450 nm with an Inter Med. Immuno-Reader NJ-2000.
Depletion of BSA from culture medium RPMI1640 medium (Nissui Pharmaceutical Co., Tokyo) containing 5% heatinactivated fetal calf serum (FCS, Flow Laboratories, Rockville, MD, USA) and supernatants obtained after culture of immunoglobulin-producing hybridoma cells for 24 hr in the above medium were used as test samples. An aliquot (15 ,u 1) of medium containing FCS was incubated with an equal volume of mAb-coupled affinity gel overnight at 4°C and BSA remained in the supernatants was quantified by sandwich ELISA or SDS-PAGE. For SDS-PAGE, IO,ul of the supernatants were mixed with an equal volume of sample buffer containing 0.125 M Tris-HC1, pH 6.8, 2% SDS, 20% sucrose, 10% 2-mercaptoethanol (2-ME) and 0.02% pyronin G and boiled for 5 min. The sample was then subjected to SDS-PAGE using 9% SDS-polyacrylamide gel. The affinity gel used for absorption of BSA was washed five times with 0.05% Tween-PBS and boiled for 5 min in 20,ul of sample buffer. The supernatants of the affinity gel were then subjected to SDS-PAGE.
RESULTS
Epitopes on BSA recognized by anti-BSA mAb
Binding inhibition experiments were performed to determine binding sites of mAb on BSA molecule. The results are illustrated in Fig, 1 . AB-6 inhibited the bindings of 125I-AB-4 and 125I-AB-6 to BSA molecule by 90.1% and 92.6%, respectively, at a concentration of 200 ccg/ml. Similarly, AB-4 inhibited the bindings of 1251-AB-6 and 1251-AB-4 by 93.1% and 93.3%, respectively. However, neither AB-4 nor AB-6 inhibited the binding of 1251-AB-3. Conversely, 125I-AB-3 Fig, 1 . Epitopes on BSA molecule recognized by binding inhibition assay.
Inhibitor solutions (unlabeled mAb) were added at 3 concentrations: • 2,ug/ ml; 0 20 ,u g/ml; u 200 ,u g/ml.
could not inhibit either AB-6 or AB-4 to react with BSA. These results indicated that the BSA epitopes recognized by AB-3 and the epitope recognized by AB-4 or AB-6 are different.
From the above inhibition assay, AB-4 and AB-6 seemed to recognize the identical or closely positioned epitopes on BSA molecule. However, when these mAbs were used as a inhibitor at a concentration of 20 jc g/ml, the inhibition of 1251 -AB-6 by unlabeled AB-6 (36.5%) was significantly higher than that by 1251-AB-4 (11 .9%). This finding indicated that these mAbs may recognize similar but not the same epitopes on BSA or they have differnt affinity to BSA.
Reactivity of anti-BSA mAb to albumins other than BSA The reactivities of anti-BSA mAb to human, dog, rat and mouse serum albumins and egg albumin were assessed by their inhibitory capacity for the binding of mAb to BSA. The results are depicted in Fig. 2 . All these albumins did not inhibit the bindings of both AB-3 and AB-6 to BSA at a concentration of Fig. 2 . Reactivity of anti-BSA mAb with albumins from various species by binding inhibition assay. Albumin solutions were used at 2 concentrations: 0 0.2 mg/ml; %I 2 mg/ml. 0.2 mg/ml, while the binding of AB-6, but not AB-3, to BSA was weakly inhibited by addition of rat, mouse and dog serum albumins at a concentration of 2 mg/ml. In contrast to AB-3 and AB-6, the binding of AB-4 to BSA was greatly inhibited by addition of these albumins at a concentration of 0.2 mg/ml. These findings indicated that AB-3 is specific to BSA but AB-4 recognizes an epitope present in all these albumins and AB-6 recognizes a minor epitope present in rat, mouse and dog aibumins.
Quantitative analysis of BSA present in medium Because AB-3 and AB-6 recognized different epitopes on BSA, we applied these mAbs to quantitative analysis of BSA. The results of sandwich radioimmunoassay (RIA) indicated that the best system of the sandwich ELISA could be established by the use of AB-6 as capture antibody and AB-3 as tracer antibody (data not shown). Therefore, we applied this system for sandwich ELISA. A standard curve in the sandwich ELISA is depicted in Fig. 3 . The titration was linear in the range of BSA at concentrations of 10 ng/ml to 1.5,ag/ml (linear correlation coefficient >0.98). Since only 50 ,ul of the solution was added to each well, the detectable range of the BSA in each sample should be as low as from 0.5 to 75 ng.
Depletion of BSA from culture medium Affinity gel coupled with AB-6 (9.5 mg/ml) was prepared and used for depletion of BSA from culture medium. Gel coupled with B3 (8.7 mg/ml) was used as control. Culture medium containing 5% FCS was absorbed with affinity gel and BSA remained in the supernatants and BSA bound on the gel were analyzed by SDS-PAGE and sandwich ELISA. The result of SDS-PAGE is shown in Fig. 4 . By one and two absorptions, about 75% and more than 95% of BSA were depleted from the medium, respectively (lanes 3 and 4). When hybridoma culture supernatants were used, the absorptions with the affinity gel extensively decreased BSA but unaffected the amount of immunoglobulin (also as antibody activity) in the medium (data not shown). This absorption efficiency of AB-6-bearing affinity gel was substantiated by sandwich ELISA (Table 1) . Control gel coupled with B3 did not absorb BSA (lane 5 and 6). The absorption capacity of AB-6-bearing affinity gel also indicated that 1 mole of AB-6 on the gel could bind 0.74 to 1.0 mole of BSA. The similar results were obtained by using AB-3-binding affinity gel (data not shown).
In this work,
DISCUSSION
we established three unique anti-BSA mAbs and described their immunological specificity and applications. Although all these mAbs are able to efficiently bind with BSA, it was found that AB-3 is specific to BSA but AB-4 recognizes an epitope present in human, dog, rat and mouse serum albumins, too, and that AB-6 recognizes a minor epitope present in rat, mouse and dog albumins.
The anti-BSA mAbs were applied to quantitative anlysis of BSA and depletion of BSA from medium. For quantitative analysis of BSA, we adopted sandwich ELISA with two mAbs, which recognizes different epitopes on BSA. The assay was highly specific and we could quantify BSA over a wide range of concentration (10-1,500 ng/ml). The sensitivity was higher than that in other ELISA systems (Isoai et al. 1989; Spertini et al. 1992 ) and it would be increased using more sensitive substrates such as chemoluminescent materials. Sandwich ELISA is found to be more advantageous than regular ELISA: it could specifically detect native BSA in biological samples in the presence of other proteins (Takata et al. 1989; Comuzio et al. 1991; Ho 1992) .
As to the application of mAb for depletion of BSA from medium, we used affinity gel coupled with AB-6. The gel efficiently absorbed BSA, and repeated treatment of medium resulted in almost complete depletion of BSA from the medium. FCS containing BSA as a principal constituent is frequently used for cell or tissue cultures. Therefore, when we aim isolation and purification of a certain protein or peptide such as cytokines from culture medium, in which cells producing the protein or peptide have been cultured, the presence of a large amount of BSA hampers the isolation procedure. Although chromatography using DEAE or Blue-sepharose are commonly utilized for separation of albumins, these are not specific for albumins and the efficiency is not always satisfactory (Ganz et al. 1988) . In this context, application of the present method will be provided as a quite useful method for removal of BSA.
